521 related articles for article (PubMed ID: 33105719)
21. Curcumin (Turmeric) and cancer.
Unlu A; Nayir E; Dogukan Kalenderoglu M; Kirca O; Ozdogan M
J BUON; 2016; 21(5):1050-1060. PubMed ID: 27837604
[TBL] [Abstract][Full Text] [Related]
22. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
23. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
24.
Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
[TBL] [Abstract][Full Text] [Related]
25. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
26. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
27. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
28. Curcumin: a promising agent targeting cancer stem cells.
Zang S; Liu T; Shi J; Qiao L
Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
[TBL] [Abstract][Full Text] [Related]
29. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
30. Curcumin and Heme Oxygenase: Neuroprotection and Beyond.
Mhillaj E; Tarozzi A; Pruccoli L; Cuomo V; Trabace L; Mancuso C
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100781
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
Azzini E; Peña-Corona SI; Hernández-Parra H; Chandran D; Saleena LAK; Sawikr Y; Peluso I; Dhumal S; Kumar M; Leyva-Gómez G; Martorell M; Sharifi-Rad J; Calina D
Phytother Res; 2024 Jun; 38(6):3169-3189. PubMed ID: 38616356
[TBL] [Abstract][Full Text] [Related]
32. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
33. Antitumor Activity of Curcumin in Glioblastoma.
Walker BC; Mittal S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
[TBL] [Abstract][Full Text] [Related]
34. "Spicing up" of the immune system by curcumin.
Jagetia GC; Aggarwal BB
J Clin Immunol; 2007 Jan; 27(1):19-35. PubMed ID: 17211725
[TBL] [Abstract][Full Text] [Related]
35. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
Soleimani V; Sahebkar A; Hosseinzadeh H
Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
[TBL] [Abstract][Full Text] [Related]
36. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
37. Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability.
Nocito MC; De Luca A; Prestia F; Avena P; La Padula D; Zavaglia L; Sirianni R; Casaburi I; Puoci F; Chimento A; Pezzi V
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680593
[TBL] [Abstract][Full Text] [Related]
38. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
[TBL] [Abstract][Full Text] [Related]
39. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of curcumin on prevention of drug-induced nephrotoxicity: A review of animal studies.
Motaharinia J; Panahi Y; Barreto GE; Beiraghdar F; Sahebkar A
Biofactors; 2019 Sep; 45(5):690-702. PubMed ID: 31246346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
